HYLG:NYE-Global X Funds - Global X Health Care Covered Call & Growth ETF (USD)

ETF | Others |

Last Closing

USD 25.1661

Change

-0.15 (-0.60)%

Market Cap

N/A

Volume

272.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.25 (+1.23%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.04 (-0.07%)

USD 36.47B
DFAC Dimensional U.S. Core Equity 2..

-0.03 (-0.09%)

USD 31.32B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 26.94B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 26.72B
DTB DTE Energy Company 2020 Series

+0.15 (+0.75%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-1.52 (-2.76%)

USD 15.23B
AVUV Avantis® U.S. Small Cap Value..

+0.29 (+0.31%)

USD 14.03B
JAAA Janus Detroit Street Trust - J..

-0.02 (-0.04%)

USD 13.91B
CGDV Capital Group Dividend Value E..

-0.08 (-0.22%)

USD 11.53B

ETFs Containing HYLG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.53% 36% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.53% 37% F 43% F
Trailing 12 Months  
Capital Gain 4.55% 25% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.55% 29% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.58% 55% F 42% F
Dividend Return 3.90% 62% D 43% F
Total Return 2.33% 76% C+ 54% F
Risk Return Profile  
Volatility (Standard Deviation) 5.31% 76% C+ 90% A-
Risk Adjusted Return 73.50% 81% B- 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike